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Abstract 
Marker-free transgenic crops confer several advantages over transgenic crops 
equipped with selection genes coding e.g. for antibiotic resistance. Firstly, the 
European Union has prepared a guidance document for risk assessment of GM-crops 
to be introduced in the environment (E.U. Joint Working Group on Novel Foods and 
GMO’s, 2003). In this document based on compliance to consumer demands the EU 
encourages to “avoid or minimise the inclusion of superfluous transgenes or 
sequences”. EU thus promotes the use of clean vector systems. Secondly, the number 
of selection genes allowing the preferential growth of transformed cells and tissues is 
limited. Often a gene transfer protocol for a specific crop or even a cultivar depends 
on the use of one specific selectable marker gene. Hence, stacking of genes within the 
same transgenic line is difficult once a selectable marker gene has been introduced. If 
these marker genes can be removed, the subsequent introduction of the next gene-of-
interest is greatly facilitated. At Plant Research International a system has been 
developed for specific elimination of any introduced DNA/gene sequences using site-
specific recombination combined with selection for successful removal using a nega-
tive selection system. Completely marker-free transgenic plants have been obtained 
using a model vector, both in an efficient transformation system (strawberry) as well 
as in a non-efficient transformation system (apple). Frequencies were more than 
adequate. Presently a versatile vector set providing a choice of several selectable 
markers and carrying a multiple cloning site for receiving cassettes of the gene-of-
interest is available for application in, amongst others, fruit crops. 
 
BACKGROUND 
Genetically modified (GM) food products are looked upon with a certain degree of 
mistrust by the majority of European consumers. Almost 50% of consumers think that 
GM food is less safe for human consumption than non-GM food, 33% are not sure. Only 
20% of the consumers know that there is no scientific basis to these doubts on food safety. 
While on the one hand players in the food production chain, such as breeding companies, 
growers/farmers and biotechnology firms, are convinced of the technical and economic 
benefits (Graff and Newcombe, 2003), the consumers on the other hand perceive risks to 
human health, to the environment and to biodiversity. In the USA and other countries 
around the globe, e.g. Argentina, Canada, China and India, GM crops are increasingly 
implemented in agriculture, however, the European input in research and development of 
GM crops has been reduced since 1998. This de-facto moratorium on the introduction of 
new GM crops has been in force since 1999. As a consequence of this, 51% of the 
European Small and Medium Enterprises (SMEs) at present do not use genetic 
engineering approaches, most of them indicated that there has been a change in their 
strategy in the last few years abandoning GM related R&D projects (Menrad and Menrad, 
2003). 
In July 2003, the ban on import of GM food products was lifted by the European 
Union (EU), with the proviso that all products containing more than 0.9% of EU-
approved GM material have to be labeled. Also, the European Parliament has formulated 
guidelines based on their desire to provide European consumers with a choice to either 
accept or avoid the consumption of any GM or GM-derived food products. For this, 
completely separate production and processing chains will have to be set up. In practice, 
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this might turn out to be too expensive for the industry, presenting yet another barrier to 
the implementation of GM food in Europe. Another consequence of this EU policy is the 
negative impact it has on imports of food from the USA and the reluctance of developing 
countries to grow GM crops out of fear of reducing their export possibilities to the EU. 
In order to change the perception of EU consumers it might not be advisable to 
force GM crops and food upon them by enforcing official WTO rules and by pressure 
from the USA. Instead, consumers should regain confidence and trust in their scientists 
and government organizations. This can only be achieved by communicating clearly the 
benefits of particular GM crops and by highlighting the relevance of these crops to the 
individual consumer. Consumers should be able to relate to the goals of the modification 
and to the way these goals are achieved. If applicable, it should be explained that 
alternatives do not really exist or are less beneficial than the GM approach. In parallel to 
this, technical solutions to some of the concerns that consumers expressed are sought by 
science and can be applied.  
In a ‘Guidance Document for the risk assessment of GM plants and derived food 
and feed’ by the Joint Working Group on Novel Foods and GMOs prepared for the EU, 
recommendations include the encouragement of notifiers to develop GM crops in which 
only DNA essential to the desired modification is introduced, e.g. clean vector 
technology. Overall, three principle ways are identified: 
- avoid or minimize the inclusion of superfluous transgenes or sequences 
- avoid or minimize superfluous expression of the transgene 
- avoid or minimize the dispersal of transgenes in the environment. 
Plant Research International has added to this list the preferential use of gene 
sequences or promoters which are species- or at least plant-derived. This, combined with 
PRIs own clean vector system and transparent communication on PRI arguments why and 
when to use GM technology, will hopefully contribute to a broader public acceptance of 
genetic modification of plants. 
 
CLEAN VECTOR TECHNOLOGY 
Clean vector technology aims to produce GM plants with only the gene-of-interest 
as the newly introduced gene function, without any superfluous gene sequences. 
Primarily, the goal is to avoid the use or the continued presence of antibiotic resistance 
genes as selectable markers. Four approaches to achieve this can be followed. 
 
A. No Selectable Marker 
Here, GM plants are produced by Agrobacterium inoculation followed by 
regeneration of shoots without the use of a selectable agent. This will lead to a (great) 
number of plants, the majority of which are non-transgenic. However, depending on the 
regeneration and gene transfer frequencies, some plantlets will be transgenic and they will 
have to be identified, e.g. by a dedicated PCR screening on DNA of several sets of pooled 
plants. A prerequisite is a regeneration/transformation protocol of high efficiency. So far, 
this method is limited to model species and a low number of specific crop cultivars, e.g. 
in potato. 
 
B. Cotransformation 
In this system the selectable marker gene is physically separated from the gene-of-
interest. This can be on different T-DNAs residing on the same or on separate binary 
vector(s). The separate binary vectors can be present in the same or in separate 
Agrobacterium strains. The two T-DNAs should become integrated in two genetically 
unlinked loci. After selection for the GM plants by growth on antibiotic or herbicide 
containing media subsequent segregation after sexual crossing of resistant regenerants 
should result in GM plants equipped only with the gene-of-interest. A prerequisite here is 
that the crop can be sexually propagated without losing too many traits or cultivar identity 
and this within a reasonable time frame. For vegetatively propagated crops or crops with a 
very long sexual cycle, such as tulip or apple, this approach is less feasible. 
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C. Non-Antibiotic-Based Selection 
The most well known example in this respect is, of course, herbicide tolerance. 
However, there might be aspects of this that can be considered undesirable by certain 
consumer groups. An alternative system that was developed recently is based on 
metabolic processes, more particularly on the carbohydrate metabolism. The phospho 
mannose isomerase (PMI) system is based on the fact that plant cells in tissue culture 
cannot metabolize mannose and therefore, cannot grow on medium with this compound 
as a sole source of carbon. By providing GM cells with a gene converting mannose into 
fructose this barrier is overcome and GM plantlets can be obtained. As a consequence, 
however, they then still carry this bacterium-derived selectable marker gene at a stage 
where it is no longer actually needed, i.e. in crop cultivation. 
 
D. Excision by Recombination 
In this approach selectable marker genes or rather any unwanted (or no longer 
wanted) gene sequence, can be physically removed from the GM cells or regenerated GM 
plants. A recombinase enzyme working on two specific recombination sites is necessary. 
All of this has to be introduced into the primary transformants, next to the gene-of-interest 
and the selectable marker gene. Placing everything, which has to be removed ultimately, 
between the recombination sites ensures that in the final GM plant product only the gene-
of-interest remains. Control over the recombinase activity is essential. This can be 
achieved by regulating or inducing expression of the recombinase gene or by inducing 
recombinase enzyme activity. Problems related to this technique are leakiness of the 
recombinase regulation, effectiveness of the induction process and recovery of 100% 
homogeneous recombined GM plants. Using a negative selection marker for transgenic, 
non-recombined cells or plantlets can cover this last aspect. This means that the prolonged 
presence of the negative selection gene will lead to cell death or an easily identifiable 
aberrant phenotype. Only the desired marker-free plants survive or will look normal. 
The induced expression of a recombinase gene (Cre) is reported by Zuo et al. 
(2001), where a promoter is used comprising an estrogen receptor-based transactivator. 
Ebinuma et al. (1997) used the ipt gene as a phenotypical negative selection marker, the 
presence of which results in an aberrant phenotype. At Plant Research International, we 
use a synthetic copy of the recombinase (R) gene of Zygosaccharomyces rouxii, which is 
fused to the ligand binding domain (LBD) of a corticosteroid receptor. The R gene is 
continuously expressed, but the protein is inactive due to the translational fusion to LBD. 
Activity can be re-established by treatment with dexamethason (DEX). A dual positive-
negative selectable marker consisting of a fusion between the nptII gene (positive) and the 
codA gene (negative) are also a part of the PRI system. The nptII gene provides the cell 
with the competence to grow on medium supplemented with e.g. the antibiotic 
kanamycin, i.e. positive selection. The cytosine deaminase (codA) gene product converts 
fluorocytosine (FC; non-toxic) into the toxic fluorouracil (FU), hence cells carrying this 
gene will die on medium with FC, i.e. negative selection. As stated earlier all of these 
elements are placed between the two Rs recombination sites.  
The steps required for the production of marker-free GM plants are: 
1) Inoculation of explants with Agrobacterium carrying the appropriate vectors as binary 
plasmids, according to established protocols. 
2) Selection of transgenic material by growth on media containing antibiotics, again 
according to existing protocols 
3) Induction of recombinase activity by applying a DEX treatment 
4) Selection for marker-free plantlets by applying regeneration protocols in the presence 
of FC as a negative selectable agent for non-successful recombination events 
5) A thorough molecular characterization of the end products should confirm the 
transgenic and marker-free nature of the plants produced. 
The model construct has been successfully applied in potato, strawberry and apple 
(Schaart et al., 2004); the first two representing efficient transformation systems and the 
latter being much more recalcitrant. So far, the system of recombinase activity inhibition 
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and induction by DEX did not prove to be 100% effective. However, combined with the 
existing protocols and tissue culture/regeneration expertise in the crops tested, it easily led 
to many homogeneous marker-free GM plants, indicating that 100% effectiveness is not 
required.  
At present, we are testing the efficiency of these new vectors based on the 
‘standard’ vector. In apple, a gene conferring scab resistance derived from barley was 
equipped with the rubisco promoter of chrysanthemum for application in our marker-free 
system; in strawberry a strawberry disease-resistance gene was combined with a 
strawberry tissue-specific promoter. This concurs with the Plant Research International 
strategy for the production of a new generation of GM crops: marker-free, containing 
preferably a combination of a plant (or species) derived promoter and a plant (or species) 
derived gene (see earlier). This, we sincerely hope, will lead to a broader acceptance of 
these crops by a majority of the public, although it is acknowledged that this approach 
represents merely a technical solution to some of the objections, and not an answer to 
every issue raised by consumers at the moment. 
Plant Research International is willing to enter into collaborations with interested 
parties to apply the system on specific crops of interest. 
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Figuress 
 
 
 
Fig. 1. A model vector, pRCNG, is presented showing all the aforementioned elements. In 
addition it contains the GUS coding region without a promoter. One Rs site is 
present between the R gene and the 35S promoter driving its expression. Upon 
recombination the 35S promoter is combined with the gus gene leading to GUS 
positive staining as a confirmation of the recombination event. A copy of the hpt 
gene outside the Rs sites in this model vector allows further use of positive 
selection when required. 
 
 
 
 
Fig. 2. A ‘standard’ vector has been assembled with only the elements needed, now 
including promoter-driven R expression between the Rs sites and a multiple 
cloning site (MCS) outside them allowing introduction of any gene (expression) 
cassette leading to the trait of choice. 
 
 
LB RB 
Rs site 
MCS or GENE-of- 
INT EREST 
Figure 2. The standard MF-vector
(MF= marker-free)
DEX treatment
LBRB
Final situation 
nptII
Recom-
binase R LBD
Rs site 
Rs site
GENE-of-
INTEREST
codAP 
P
35S   P 35S P
 
LB RB GUS
Rs site 
35S P hpt
Figure 1 The pRCNG modelvector
DEX treatment
LBGUS35S P hptRB Final situation 
nptIIRecombi- nase R LBD 
Rs site
Rs site 
35S P codA
 436
 
